Preliminary assessment of Hedychium coronarium essential oil on fibrinogenolytic and coagulant activity induced by Bothrops and Lachesis snake venoms by Cíntia A SF Miranda et al.
Miranda et al. Journal of Venomous Animals and Toxins including Tropical Diseases 2014, 20:39
http://www.jvat.org/content/20/1/39RESEARCH Open AccessPreliminary assessment of Hedychium coronarium
essential oil on fibrinogenolytic and coagulant
activity induced by Bothrops and Lachesis snake
venoms
Cíntia A SF Miranda1, Maria G Cardoso1,3*, Mariana E Mansanares2, Marcos S Gomes1 and Silvana Marcussi1Abstract
Background: The search for new inhibitors of snake venom toxins is essential to complement or even replace
traditional antivenom therapy, especially in relation to compounds that neutralize the local effects of
envenomations. Besides their possible use as alternative to traditional antivenom therapy, some plant species
possess bioactive secondary metabolites including essential oils, which can be extracted from weeds that are
considered substantial problems for agriculture, such as Hedychium coronarium.
Methods: The essential oils of leaves and rhizomes from H. coronarium were extracted by hydrodistillation, and
their potential inhibitory effects on the coagulant and fibrinogenolytic activities induced by the venoms of Lachesis
muta, Bothrops atrox and Bothrops moojeni were analyzed. Citrated human plasma was used to evaluate the
clotting time whereas changes in fibrinogen molecules were visualized by electrophoresis in polyacrylamide gel.
The experimental design used for testing coagulation inhibition was randomized in a 3 × 2 factorial arrangement
(concentration × essential oils), with three replications. The essential oils were compared since they were extracted
from different organs of the same botanical species, H. coronarium.
Results: The results suggest that the oils interact with venom proteases and plasma constituents, since all oils
evaluated, when previously incubated with venoms, were able to inhibit the clotting effect, with less inhibition
when oils and plasma were preincubated prior to the addition of venoms.
Conclusions: Thus, after extensive characterization of their pharmacological and toxicological effects, the essential
oils can be used as an alternative to complement serum therapy, especially considering that these plant
metabolites generally do not require specific formulations and may be used topically immediately after extraction.
Keywords: Volatile oils, Weeds, Natural inhibitors, Antivenom therapyBackground
Weeds are a serious threat to the conservation of native
plants and cultivated crops because they alter the bal-
ance of ecosystems, with consequent damage to agricul-
ture. These plants have been removed by physical
methods, including burning and hoeing, or more com-
monly by chemical methods such as the use of synthetic* Correspondence: mcardoso@dqi.ufla.br
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unless otherwise stated.herbicides [1]. Although efficient from a functional point
of view, these agrochemicals present low selectivity, act-
ing indiscriminately on invasive and cultivated species
while changing them morphologically and physiologic-
ally. These alterations hamper the determination of
current and especially future changes to the animal spe-
cies that consume these plants [2].
Control of weeds by manual hoeing at ideal times does
not reduce crop yields in relation to the use of herbi-
cides [1]. Considering this, it is important to propose an
alternative destination for weeds, one that is economic-
ally and ecologically sustainable, such as the exploitationl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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among which we highlight the essential oils.
Essential oils are complex mixtures of volatile, lipo-
philic and odoriferous substances from various plant
tissues. They are composed primarily of terpenoids, pre-
dominantly monoterpenes, sesquiterpenes and their oxy-
genated derivatives such as alcohols, ketones, aldehydes,
esters, phenols and oxides. These metabolites play essen-
tial biological functions for survival and adaptation of
the plant to the environment, as well as present pharma-
cological activities of medical-scientific interest [3].
Standing out among the invasive exotic species is
Hedychium coronarium, an aquatic monocot belonging
to the botanical family Zingiberaceae, widely distributed
in Brazil and adapted to cerrado fields, coastal forests of
Serra do Mar, araucaria rainforests, coastal and inland
forests of Bahia, caatinga and Upper Paraná Atlantic
forests [4].
The biological potential of essential oils extracted from
rhizomes of this species has been widely studied includ-
ing reports of their antibacterial, antifungal, larvicidal
and antioxidant activities [5-9]. To the best of our know-
ledge, research with essential oils extracted from leaves
is restricted to a single work, which reports antioxidant,
larvicidal, antifungal and antibacterial activities [9]. In
addition, this is the first study that evaluates the proper-
ties of oils extracted from the rhizomes and leaves of
the species H. coronarium, by analyzing their potential
pharmacological effects on coagulation and fibrinogen-
olysis related to snake envenomation. The results de-
scribed herein represent a screening of the inhibiting
activity of such oils against effects induced by snake
venom proteases. This partial characterization may be
used to guide further studies, especially in vivo, aiming
at future applications of these oils.
Snake envenomations comprise a public health issue
in Brazil that deserves the attention of health authorities,
and mainly affects rural workers [10]. Snakes of the
Bothrops genus are responsible for most accidents in
Latin America, although the Lachesis genus, widely
distributed in humid regions such as the remote rain-
forest areas in Central America and South America, is
responsible for accidents of equal severity, resulting in
prominent local effects, permanent sequelae and even
death [11].
Snake venoms are composed mainly of proteins with
enzymatic activity that belong to different classes, such
as L-amino acid oxidases, phospholipases A2, serine
proteases and metalloproteases, the two latter being pri-
marily responsible for effects on hemostasis [11]. The
combination of these protein compounds is directly
related to the damage caused by these venoms, whose
pathophysiology includes local effects (intense pain,
edema, hemorrhage and necrosis) and/or systemiceffects, such as nausea, coagulopathy, hypotension,
cardiovascular shock and kidney disorders [12].
Although their use for the treatment of snakebites is
traditional in many countries, plant extracts have been
shown empirically to be a promising alternative for this
purpose, but without scientific evidence of their efficacy
[13]. Several studies are speculating on the use of plant
extracts as sources of molecular prototypes which can
be used in the treatment of snake envenomations, or to
complement the traditional antivenoms, which have
shown little effectiveness in minimizing the local dam-
age [3,13-19]. However, studies employing essential
oils for that purpose are still scarce [18].
With that in mind, the present study aimed to evaluate
the inhibitory potential of essential oils extracted from
leaves and rhizomes of H. coronarium species against
the coagulant and fibrinogenolytic activities induced by
Lachesis muta, Bothrops atrox and Bothrops moojeni
snake venoms.
Methods
Collection and registration of plant material
Specimens of the plant species Hedychium coronarium
were collected at the Federal University of Lavras
(UFLA), in Lavras, MG (21° 14 ′S, longitude 45° 00′ W
Gr and 918 m altitude), at around 8:00 am on February
25th, 2012. Young leaves (rib and limb) and rhizomes of
mature plants at the stage of full flowering were har-
vested. Species identification was kindly performed
by Dr. Mariana Esteves Mansanares, Department of
Biology of UFLA and exsiccates were deposited in
the ESAL Herbarium at UFLA under the registration
number 26942.
Essential oil extraction
The essential oils from fresh leaves were extracted by
steam distillation using a modified Clevenger apparatus,
adapted to a round-bottom flask with a capacity of 4 li-
ters, for a period of two hours [20]. Resulting samples
were centrifuged for five minutes at 965.36 g, and the
essential oils were separated with a Pasteur pipette,
disposed in amber glass bottles and stored at 4°C. The
composition of the essential oils was determined by Mi-
randa [21]. The oil volumes used during the analyses
were selected from the results obtained in toxicity tests
(results not shown).
Obtaining human citrated plasma
Blood samples were obtained from the researchers in-
volved in the work, who presented good health and nor-
mal exams of bleeding time (BT), clotting time (CT),
prothrombin activity time (PAT), and partially activated
thromboplastin time (PATT). The samples were collected
in BD Vacutainer® (Becton, Dickinson and Company, USA)
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0.105 mol (3.2%) in the proportion of nine parts of
blood to one part of citrate solution, as recommended
by the Clinical and Laboratory Standards Institute
(CLSI). The original project whose present work is included
was approved by the Ethics Committee for Human Re-
search of UFLA, protocol number 09978312.8.0000.5148.
Snake venoms
Crystallized venoms corresponding to a single specimen
of each snake species (Lachesis muta, Bothrops atrox
and Bothrops moojeni) were purchased from Bio-Agents
(Serpentário Proteínas Bioativas Ltda., Batatais, Brazil), and
stored at 4°C until used in the biological assays. At this
point, venoms were dissolved in phosphate buffered saline
(PBS) at different concentrations (10, 5, 1 and 0.5 mg/mL).
Effects of essential oils on coagulation: induction and/or
inhibition of clot formation
The coagulant capacity of essential oils was previously
evaluated with adaptations related to the volumes of
samples evaluated [22]. Volumes of 200 μL of citrated
human plasma had their temperatures previously stabi-
lized in a water bath at 37°C. Then, essential oils were
added separately in tubes at different volumes (0.6 and
1.2 μL) and the reaction mixtures remained under obser-
vation at 37°C for 24 hours. The observation was contin-
ued by gentle agitation every five minutes for a period of
45 minutes, and if no coagulation of the plasma was de-
tectable, this observation was extended for a period of
24 hours, to define plasma uncoagulability.
The inhibitory action of oils on the coagulant activity in-
duced by snake venoms was assessed with adaptations.
Pilot tests were conducted to determine the concentration
of each venom able to coagulate 200 μL of citrated plasma
in a time interval between 40 and 120 seconds at 37°C.
We evaluated two possible mechanisms of interaction
for the oil molecules: firstly, with fibrinogen, and, sec-
ondly, with snake venom proteases. Accordingly, the first
assay was carried out by preincubating plasma (200 μL)
with essential oils (0.6 and 1.2 μL) at 37°C for 15 mi-
nutes, followed by the addition of 1 μL (10 μg) of each
venom (L. muta, B. atrox and B. moojeni) separately,
measuring the time for the formation of a rigid clot. The
second assay was performed by preincubation of essen-
tial oils (0.6 and 1.2 μL) with the same venoms (10 μg;
50 μg/mL) for 15 minutes at 37°C, followed by the
addition of plasma (200 μL) and measurement of the
clotting time.
Effects of essential oils on the fibrinogen structure and
the fibrinogenolytic activity induced by venoms
The activities were carried out with modifications [23].
The essential oils (0.6 and 1.2 μL) were incubated withbovine fibrinogen (60 μg) for 90 minutes at 37°C in a
final volume of 25 μL (PBS). The reactions were stopped
by addition of 10 μL of bromophenol blue solution
[0.05 M Tris-HCl, pH 8.0, comprising 10% (v/v) glycerol,
10% (v/v) mercaptoethanol, 2% (w/v) sodium dodecyl
sulfate (SDS) and 0.05% (w/v) bromophenol blue] and
boiling the samples for five minutes in a water bath. The
samples were analyzed by polyacrylamide gel electro-
phoresis at 12% (acrylamide: bisacrylamide, 19:1) in the
presence of SDS (SDS-PAGE) under denaturing condi-
tions [24]. A sample control containing only fibrinogen
was used for the visualization of the band pattern corre-
sponding to the α, β and γ chains of fibrinogen.
The inhibitory potential of the essential oils on the
proteolytic action of L. muta, B. atrox and B. moojeni
venoms was assessed by SDS-PAGE after preincubation
of samples. We evaluated possible interactions between
the essential oils (0.6 and 1.2 μL) and proteases present
in the venoms (30 μg) by incubating them (final volume
of 25 μL; PBS) for 30 minutes at 37°C with subsequent
addition of fibrinogen (60 μg) and incubation for 90 mi-
nutes at the same temperature. Possible interactions be-
tween oil molecules and fibrinogen were considered in
another assay, by preincubating bovine fibrinogen (60 μg)
and essential oils (0.6 and 1.2 μL) for 30 minutes at 37°C
with subsequent addition of each venom (L. muta, B. atrox
and B. moojeni; 30 μg) and incubation for 90 minutes at the
same temperature.
The reactions were stopped by addition of 10 μL of
bromophenol blue solution and boiling for five minutes
in a water bath, followed by analysis on SDS-PAGE under
denaturing conditions [24].
Statistical analysis
The experimental design used for testing the inhibitory ac-
tion on coagulation was randomized in a 3 × 2 factorial
arrangement (concentration × essential oils), with three
replications. The essential oils were compared since they
are extracted from different vegetal organs of the same bo-
tanical species, H. coronarium. Significant factors by the F
test (p < 0.05) were tested for average (Scott-Knott 5%) for
the determination of the models. Data were analyzed using
the statistical analysis system variance for balanced data
Sisvar described by Ferreira [25].
Results and discussion
Miranda [21] identified 99.2 and 99.3% of the chemical
constituents of the essential oils of rhizomes and leaves
of H. coronarium, respectively, with the two oils being
composed entirely of terpenoids. Among these terpene
constituents, the oil extracted from rhizomes showed
98.2% monoterpenes and 1% sesquiterpenes, while that
from leaves presented 84.3% monoterpenes and 14.9%
sesquiterpenes. Among the major compounds of the oil
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1.8-cineole (23.6%) and α-pinene (13.1%), whereas leaf
oil presents the monoterpenoids β-pinene (46.9%) and
α-pinene (19.2%), and the sesquiterpene β-caryophyllene
(13.2%). Such variability observed in the chemical composi-
tions of the essential oils of leaves and rhizomes of a botan-
ical species is commonly observed, due to the fact that the
location and distribution of secondary metabolites occur in
a characteristic manner between different parts of the same
plant [26]. Additionally, the individual chemical com-
positions of essential oils directly influence the bio-
logical activities and pharmacological effects of these
secondary metabolites.
The search for natural products with antiophidian
properties has motivated studies to characterize the
toxic and pharmacological properties of extracts and es-
sential oils from several plant species, attributing major
economic and ethnopharmacological importance to the
secondary metabolites. In this context, we highlight the
widespread use of popular plant species with antiophi-
dian properties, capable of neutralizing the local effects
of venoms, the lack of studies that investigate the antio-
phidian potential of essential oils and the importance of
exploring the pharmacological potential of secondary
metabolites extracted from invasive species, making this
an innovative and valuable scientific research area.
Thus, the study of the antiophidian properties of es-
sential oils extracted from rhizomes and leaves of H. cor-
onarium, such as their inhibitory effects on coagulation
and fibrinogenolysis induced by the venoms of L. muta,
B. atrox and B. moojeni, evaluated in the present work,
may result in information that indicates the use of these
compounds not only in the treatment of snakebites but
also in the therapy of diseases responsible for hemostatic
disorders or inflammatory processes. In addition, new stud-
ies that will complement the functional characterization of
oils are being conducted based on the evaluated experimen-
tal conditions and the results observed in this study.
The essential oils showed no effectiveness in inhibiting
the fibrinogenolysis induced by the venoms evaluated,
when previously incubated with venoms or fibrinogen.
Throughout the 24-hour observation period, the es-
sential oils tested did not cause coagulation of citrated
human plasma at the volumes tested (0.6 and 1.2 μL),
thus indicating a lack of coagulant potential.
By previously incubating citrated human plasma at
37°C in the presence of essential oils from rhizomes and
leaves of H. coronarium, with subsequent addition of the
venoms of L. muta and B. atrox, a decrease in the clot-
ting times induced by the venoms could be observed.
For L. muta venom (CT = 45.0 ± 1.5 seconds), clotting
times of 32.7 ± 1.8 and 36.0 ± 1.0; 35.7 ± 0.7 and 40.5 ±
0.8 (corresponding to oil volumes of 0.6 and 1.2 μL) for
oils of rhizomes and leaves, respectively, were observed.For B. atrox venom (CT = 106.5 ± 0.9 s), the oil from
leaves presented significant changes, with clotting times
of 83.1 ± 0.6 and 85.2 ± 1.1, corresponding to oil volumes
of 0.6 and 1.2 μL, and 78.6 ± 1.0 for the rhizome oil
volume of 0.6 μL. On the other hand, the oils from the
different parts of H. coronarium did not statistically alter
the clotting time induced by the venom of B. moojeni
(Figure 1).
The data presented in Figure 1 show a procoagulant
action previously unreported in the literature with re-
gard to the effects of antiophidian plant extracts. This is
possibly due to the structural variability of molecules,
mainly of hydrophobic character, present in essential oils
and absent in most aqueous or hydroalcoholic extracts
described in the literature. The results suggest that the
oils possibly interact with plasma proteins involved in
the coagulation cascade, making them more susceptible
to the proteolytic action of venoms and consequently
accelerating the plasma coagulation. This interaction prob-
ably occurs between individual constituents of the essential
oils and proteins such as thrombin, fibrinogen or fibrin,
which are the major targets of coagulant toxins, thereby
acting as procoagulants.
Given the limitations of these tests, such as the max-
imum sample volume in relation to the plasma volume
and limited available quantities of oils for the assays,
future studies should be performed using variations in
incubation times, volumes of plasma, oils and venoms,
as well as the analysis of the effects of oils on isolated
toxins.
By analyzing the effect of preincubation of snake
venoms with the essential oils on the clotting time of
citrated plasma, we observed that the oils from rhizomes
and leaves of H. coronarium were able to extend the clot-
ting time induced by all the venoms evaluated, being poten-
tial anticoagulants. Additionally, the results showed that the
essential oil from leaves extended plasma coagulation time
induced by all three venoms evaluated at higher levels than
those obtained from rhizome oil (Figure 2).
The clotting time of L. muta venom (52.2 ± 0.5 sec-
onds) was extended by the oil from leaves to 81.3 ± 1.8
and 97.2 ± 1.5, corresponding to volumes of 0.6 and
1.2 μL, respectively. The clotting time of B. atrox (100.8 ±
2.0) was extended by the same oil to 162.9 ± 0.8 and
183.9 ± 1.3 μL, respectively.
Statistically significant variations in clotting times were
produced by employing two different volumes (0.6 and
1.2 μL) of the essential oil of leaves, with no significant
differences between the results obtained with the same
volumes of rhizome oil. The oil obtained from rhizomes,
when previously incubated with venoms, prolonged clot-
ting times induced by L. muta to 77.4 ± 07 and 76.5 ±
1.8, and by B. atrox to 140.7 ± 2.2 and 147.3 ± 0.7, with
values corresponding to volumes of 0.6 and 1.2 μL,
Figure 1 Effect of essential oils on the coagulation of human plasma induced by Bothrops and Lachesis snake venoms after previous
incubation of citrated human plasma at 37°C with different volumes of essential oils extracted from rhizomes and leaves of H.
coronarium, followed by addition of the venoms of Lachesis muta, B. moojeni and B. atrox (50 μg/mL). (A) Lachesis muta inducing clotting.
(B) Bothrops moojeni inducing clotting. (C) Bothrops atrox inducing clotting. Mean values of the clotting time followed by the same letter,
in uppercase to compare the essential oils analyzed and in lowercase for comparison between volumes of the same essential oil, do not
differ significantly at 5% probability by the Scott-Knott test.
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leaves with venoms before addition of the plasma re-
sulted in greater inhibition of the B. moojeni venom-
induced clotting effect in comparison to the tests with
preincubation of the oils with the plasma. The clotting
time induced by B. moojeni venom (108.3 ± 0.4) was pro-
longed to 227.4 ± 1.6 and 283.5 ± 1.5 for the oil volume
of 0.6 μL, and to 228.3 ± 2.1 and 288.0 ± 2.5 for 1.2 μL,
corresponding to oils from rhizomes and leaves, respect-
ively (Figure 2).
These findings suggest possible interactions between
terpene compounds present in the oils and proteases
present in the venoms, which are responsible for their
clotting effect. Considering the different clotting times
obtained with the different oils and different snake
venoms, an inhibition pattern could not be detected,
so that several terpenes may have been responsible for
specific interactions with different toxins present in
the venoms evaluated. Possible inhibition mechanisms
may include the scavenging of ion cofactors by the oils,
terpenes binding to specific catalytic sites or acting as
ligands of enzymatic cofactors, and terpenes interact-
ing with hydrophobic amino acids of the toxins, chan-
ging their three dimensional conformation, solubility
and hence interfering with their proteolytic activity.Future trials to evaluate the effects of oils and their
major isolated constituents on molecules or classes of
venom toxins can provide accurate information about
the interactions, predicting specificity and inhibition
mechanisms. The biological effects of essential oils are
rarely associated with a single constituent, but rather
with a group of secondary metabolites, which corrobo-
rates the observations made in this work [27]. This
differentiated interaction of essential oils from leaves
and rhizomes of H. coronarium with the venoms of L.
muta, B. moojeni and B. atrox, in which the oil from
leaves induced higher inhibition of coagulation, sug-
gests that its higher content of sesquiterpenoids (14.9%
in comparison to merely 1% in the oil from rhizomes)
may account for greater antioxidant efficiency and may
be associated with the inhibition of toxins that exert
pathophysiological effects partially attributable to oxi-
dative actions.
In general, the composition of venoms present minor
variations among species of the same genus (e.g. B. atrox
and B. moojeni) and higher among species of different
genera (e.g. B. atrox and L. muta). Nevertheless, the results
contradict this observation, suggesting the presence of
homologous proteases in the venoms of B. atrox and L.
muta, largely responsible for the induction of coagulation
Figure 2 Effect of essential oils on the coagulation of the human plasma induced by Bothrops and Lachesis snake venoms after
previous incubation of Lachesis muta, B. moojeni and B. atrox (50 μg/mL) snake venoms at 37°C with different volumes of essential
oils extracted from rhizomes and leaves of H. coronarium, followed by addition of citrated human plasma. (A) Lachesis muta inducing
clotting. (B) Bothrops moojeni inducing clotting. (C) Bothrops atrox inducing clotting. Means followed by the same letter, in uppercase for comparison
between the essential oils analyzed and in lowercase to compare volumes of the same essential oil, do not differ significantly at 5% probability by the
Scott-Knott test.
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chemical compositions of venoms are related not only to
distinct genera and species, but also to the age, sex and geo-
graphic region of the animal, this latter being related to dif-
ferences in diet, climate, and other factors [28].
The effect of venoms on blood hemostasis is mainly
associated with the action of proteases, which can act on
factors of the beginning of the coagulation cascade, as
well as on fibrinogen, thrombin, fibrin and on platelet
surface receptors [29-36]. These various targets for pro-
teases hamper the development of hypotheses on the
action mechanisms of natural inhibitors, such as the es-
sential oils evaluated in the present study.
There are few reports in the literature on the antiophi-
dian properties of essential oils. The inhibitory effect of
extracts and essential oils from Nectandra angustifolia
leaves on the hemolysis and coagulation induced by B.
neuwiedi venom were evaluated, showing that the essen-
tial oil was only effective in inhibiting coagulation [18].
The monoterpenes α-pinene, β-pinene and limonene
were the major constituents identified in the essential
oils evaluated and were considered by these authors as
possible coagulation inhibitors. Additionally, these authors
expressed the need for further analysis of the active compo-
nents of these oils, since there is no conclusive data onmechanisms of specific interactions between plant and
venom molecules.
Fibrinogen, a dimeric plasma glycoprotein of 340 kDa
composed of six polypeptide chains (α, β, γ), participates
in the coagulation cascade, and is converted by thrombin
to fibrin monomers [37]. This protein has been exten-
sively used for the evaluation of the potential fibrinogen-
olytic effects of snake venoms, and for the verification of
potential antiophidian properties of natural compounds,
mainly of plant origin [3,13,15-18,38,39].
The essential oils from rhizomes and leaves of H.
coronarium showed no proteolytic effect on fibrinogen.
These essential oils were also unable to inhibit the
fibrinogenolysis induced by the venoms of L. muta, B.
moojeni and B. atrox, since electrophoretic migration
profiles observed for samples of fibrinogen incubated
with venoms were identical to those obtained with
venoms previously submitted to incubations in the
presence of oils (results not shown). These evaluations
were performed with preincubation of oils (0.6 and
1.2 μL) with fibrinogen and subsequent addition of
venoms, and/or with previous incubation of oils and
venoms and subsequent addition of fibrinogen.
These results suggest that the compounds present in
the oils may interact with specific non-fibrinogenolytic
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by snake envenomations, thus ruling out a number of
metalloproteases described in the literature, especially those
isolated from the venoms of B. atrox (batroxase, BaTX-I
botroxostatine and atroxlysin-I) and B. moojeni (BMMP-III
and BthMP) [30,31,33,34,40,41] and highlighting the
serineproteases mainly responsible for such coagula-
tion disorders [35,36,41-45].
The potential neutralization of different parts (leaves,
stems and roots) of fresh and dried Mikania glomerata
aqueous extracts on the enzymatic and pharmacological
effects of Bothrops and Crotalus snake venoms were
evaluated [13]. All extracts were active in inhibiting the
hemolytic, fibrinogenolytic and coagulant activities of
the venoms; however, the intensity of the inhibitions
showed specificity in relation to each extract acting on
each activity evaluated. The individuality observed in
these activities in the present work, may be due to the
fact that the metabolites are distributed in a particular
manner in each organ of the same plant to constitute a
characteristic chemical composition of each extract or
essential oil that is crucial for its pharmacological
activity [26].Conclusions
Although the anticoagulant action mechanisms of the es-
sential oils evaluated are still unknown, they significantly
inhibited coagulation induced by the snake venoms tested,
which suggests that they could be used as an alternative to
complement the available antivenoms, especially consider-
ing that essential oils do not require specific formulations
and their topical use may be performed immediately after
extraction. In addition, snake venoms have been widely
used in studies of normal physiological mechanisms and of
development of various diseases, considering that many hu-
man enzymes are structurally and functionally similar to
molecules present in venoms, indicating the importance of
the characterization of new natural compounds capable of
interacting with different classes of snake toxins (metallo-
proteases, serine proteases, phospholipases A2, L-amino
acid oxidases, etc.), thus directing scientific basis for the de-
velopment of new therapies. Therefore, this work is an in-
vestigative and bioprospecting basic research and further
in vivo assays should be performed. We believe that natural
products may be used to treat or combat snake envenoma-
tions and/or in the therapy of diseases responsible for
inflammatory and homeostatic processes disorders.Ethics committee approval
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